Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple mineral stop Post-Surgery agitation?

NCT ID NCT07139847

Symptom relief Sponsor: Ondokuz Mayıs University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving magnesium during back surgery can reduce the confusion and agitation some patients feel when waking up. 70 adults having a single-level lumbar microdiscectomy will receive either magnesium or a placebo. Researchers will monitor agitation, pain, and recovery times in the recovery room.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Magnesium sulfate
What this could lead to
If it works, this could offer a simple, safe way to prevent agitation after back surgery, helping patients recover more calmly.
What could go wrong
This is a small, early-stage study (70 people) and results may not apply to everyone. Magnesium can cause side effects like low blood pressure or slow heart rate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients aged 18-70 years with an ASA physical status of I or II who underwent elective single-level lumbar microdiscectomy under general anesthesia at Giresun Training and Research Hospital were included in the study population. The study population consisted of patients whose medical records contained complete perioperative and post-anesthesia care unit data required for the retrospective evaluation of intraoperative magnesium sulfate infusion and postoperative emergence agitation.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Age between 18 and 70 years ASA physical status classification I or II Scheduled for elective single-level lumbar microdiscectomy under general anesthesia Ability to provide written informed consent Exclusion Criteria: Severe cardiovascular disease History of psychiatric disorder Neuromuscular disease Pregnancy or breastfeeding Hepatic or renal dysfunction Current use of calcium channel blockers, hypnotics, anxiolytics, or antipsychotic medications Known allergy to magnesium sulfate or study-related medications Refusal to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Emergence agitation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Emergence Delirium Intervertebral Disc Displacement lumbar disk disease lumbar disk herniation, susceptibility to Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Emergence agitation Lumbar disc herniation Magnesium sulfate

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.